China SXT Pharmaceuticals, Inc. (SXTC) Form 424B5 — Oct 9, 2026
China SXT Pharmaceuticals priced a best-efforts offering of up to 8,000,000 units at $1.50 per unit (share or pre-funded warrant plus ordinary warrant) for gross proceeds of up to $12 million, with a 30-day over-allotment option for another $12 million. Univest Securities acted as exclusive placement agent on a 7.0% fee. The ordinary warrants carry a $2.75 exercise price but include a 'zero price exercise' feature with a $0.50 floor price, under which holders receive more shares as the stock price falls. The company expects no cash proceeds from warrant exercise; up to 72,000,000 shares (144 million with over-allotment) could be issued this way.
Key figures
- Gross Proceeds
- 12000000
- Offering Price
- 1.5
- Shares Offered
- 8000000
- Last Sale Price
- 0.3435
- Max Warrant Shares
- 72000000
- Over Allotment Usd
- 12000000
- Warrant Floor Price
- 0.5
- Net Proceeds Estimate
- 11060000
- Warrant Exercise Price
- 2.75
- Dilution Per New Investor
- 0.85
- Shares Outstanding Prior
- 2357498
- Placement Agent Fee Percent
- 7
- Pre Funded Warrant Exercise Price
- 0.001
- Shares Outstanding After Full Warrant Exercise
- 82357498
- Shares Outstanding After Over Allotment And Warrants
- 162357498
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.